Dr. Jerrold Vitek Performs First Commercial Surgery of Newly FDA-Approved DBS System

Platform Offers Physicians Advanced Technology to Treat Symptoms of Parkinson’s Disease 

Dr. Jerrold Vitek, MD, PhD, Head of the Neurology Department and the Director of the Neuromodulation Research Program at the University of Minnesota was the coordinating principal investigator for the INTREPID study which evaluated the safety of Boston Scientific’s Vercise DBS system in 292 patients at 23 sites and also evaluated its effectiveness. FDA approval was based on the INTREPID study.

“The Vercise DBS System changes the landscape of what physicians can do to help improve the quality of life for people living with Parkinson’s disease,” said Dr. Vitek, coordinating principal investigator for the INTREPID study. “This system provides an ability to sculpt the current field in the DBS target using novel technology that offers flexibility in programming. This flexibility allows us to target different regions of the subthalamic nucleus, which we believe will improve outcomes while reducing side effects.”

The first commercial implant in the U.S. with the Vercise System took place on Saturday, December 16, at the University of Minnesota Medical Center by University of Minnesota Medical School faculty physicians including Dr. Vitek, Michael C. Park, MD, PhD, assistant professor, Department of Neurosurgery and Lauren E. Schrock, MD, MnDrive neuromodulation faculty scholar, Department of Neurology.

The Vercise System is designed to specifically stimulate auditory nerves to produce a sense of hearing. The system’s features work together to address common challenges in DBS therapy.

Share this post

Related News

  • Pharmacology Grad Students Promote Passion for Science

    University of Minnesota Medical School Department of Pharmacology graduate students connected with kids and families at the Science Museum of Minnesota during the Women in Science & Engineering event, a hands-on science experience focused on female leaders working in a variety of scientific and engineering professions.

  • Welcome Nichole Klatt, PhD

    Dr. Klatt joins the Medical School from the University of Miami, where she was most recently an associate professor and vice-chair of research in the department of pediatrics, held the Adrienne Arsht Endowed Chair in Pediatric Clinical Research and was a member of the Sylvester Comprehensive Cancer Center.